NLSP Market Cap History



Below is a table of the NLSP market cap history going back to 1/29/2021:

Date NLSP Market Cap
1/29/202130.62M

Also see: NLSP Shares Outstanding History
and NLSP YTD Return
Mouse over chart for data details
1/29/2021
NLS Pharmaceutics is a clinical-stage biopharmaceutical company focused on the discovery and development of therapies for patients with rare and complex central nervous system disorders with unmet medical needs. Co.'s main compound mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary controlled release formulation, is being developed for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD). Co.'s focus includes its primary product candidate: Quilience, for the treatment of excessive daytime sleepiness and cataplexy associated with narcolepsy, and Nolazol, for the treatment of ADHD. We show 1 historical shares outstanding datapoints in our NLSP shares outstanding history coverage, used to compute NLSP market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NLSP market cap history over the course of time is important for investors interested in comparing NLSP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NLSP versus a peer is one thing; comparing NLSP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NLSP can fluctuate over the course of history. With this page we aim to empower investors researching NLSP by allowing them to research the NLSP market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree NLSP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
NLS Pharmaceutics (NLSP) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NMCI Market Cap History
NMMC Market Cap History
NN Market Cap History
NNDM Market Cap History
NNOX Market Cap History
NOAC Market Cap History
NOBL Market Cap History
NOGN Market Cap History
NOMD Market Cap History
NOTE Market Cap History
More Miscellaneous companies »

 

NLSP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.